Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2

NARecruitingINTERVENTIONAL
Enrollment

1,022

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

February 29, 2028

Study Completion Date

May 31, 2028

Conditions
Out-Of-Hospital Cardiac ArrestHypothermiaVentricular Fibrillation
Interventions
DEVICE

Early transnasal evaporative cooling with the RhinoChill device

Early prehospital transnasal evaporative cooling followed by systemic hypothermia to 33 degrees Celsius for 24 hours and fever control for 72 hours

Trial Locations (11)

Unknown

NOT_YET_RECRUITING

University Hospital Vienna, Vienna

RECRUITING

CHU Saint-Pierre, Brussels

RECRUITING

Erasme University Hospital, Brussels

RECRUITING

Europe Hospitals St Elizabeth, Brussels

RECRUITING

University Hospital Freiburg, Freiburg im Breisgau

NOT_YET_RECRUITING

Department of Anesthesiology, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

RECRUITING

Ljubljana University Medical Centre, Ljubljana

RECRUITING

Hospital Universitario La Paz, Madrid

RECRUITING

San Carlos Clinical Hospital, Madrid

RECRUITING

Karolinska University Hospital, Stockholm

RECRUITING

Södersjukhuset, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER